Author

E. Slot

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Organism:bacteria (other)· 1 Research Focus:cell type annotation· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. E. Oja· 1 shared A. Saris· 1 shared A. Ten Brinke· 1 shared B. J. Ignacio· 1 shared B. M. Hogema· 1 shared C. A. Ghandour· 1 shared E. J. Nossent· 1 shared E. Storkebaum· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. E. Oja

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

THRONCAT: Efficient metabolic labeling of newly synthesized proteins using a bioorthogonal threonine analog

B. J. Ignacio, J. Dijkstra, N. MoraGarcia, E. Slot, M. van Weijsten, E. Storkebaum, M. Vermeulen, K. M. Bonger

THRONCAT enables efficient, non-toxic labeling of newly synthesized proteins in various organisms using a threonine analog, demonstrating its utility in studying proteome dynamics and disease models.

bioRxiv · Mar 29, 2022Cell Biology

Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19

A. E. Oja, A. Saris, C. A. Ghandour, N. A. M. Kragten, B. M. Hogema, E. J. Nossent, L. M. A. Heunks, S. Cuvalay, E. Slot, F. H. Swaneveld, H. Vrielink, T. Rispens, E. van der Schoot, R. A. W. van Lier, A. Ten Brinke, P. Hombrink

The paper compares T and B cell responses in severe versus mild COVID-19 patients, finding impaired CD4+ T cell responses but strong IgG antibodies in severe cases.

bioRxiv · Jun 18, 2020 · PreprintImmunology